EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access

Effects of a Monophasic Hormonal Contraceptive With Norgestimate+Ethinyl Estradiol on Menstrual Bleeding: Protocol and Design of a Multicenter, Prospective, Open-Label, Noncomparative Study in Italy

Angelo Cagnacci iD, Giovanni Grandi iD, Giampiero Capobianco iD, Anna Maria Fulghesu iD, Giuseppe Morgante iD, Vincenzo Biondelli iD, Elena Piccolo iD, Elena Casolati iD, Mario Mangrella iD

JMIR Research Protocols · 2025

DOI: 10.2196/63683 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift JMIR Research Protocols, 2025. Verfasst von Angelo Cagnacci und 8 weiteren Autor:innen. Beteiligte Einrichtung: Dipartimento di Neuroscienze, Riabilitazione, Oftalmologia e Scienze Materno Infantili, Istituto di Recerca e di Cura e Carattere Scientifico (IRCSS)…. Hauptthemen laut MEDLINE: Contraceptives, Oral, Combined, Ethinyl Estradiol, Menstruation, Norgestrel. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Norgestimate (NGM) is a progestin with negligible androgenic activity that is available in combination with ethinyl estradiol (EE) as a monophasic combined oral contraceptive (COC). It has been more than 30 years since a clinical study evaluated the effects of monophasic NGM/EE on menstrual cycle characteristics in healthy women, and in the interim, there has been growing recognition that clinical trials of contraceptives should evaluate a wide range of potential positive and negative impacts for users.

Objective

The aim of this study is to investigate menstrual cycle control during the use of a monophasic COC formulation containing NGM 0.25 mg and EE 0.035 mg (Effimia; Italfarmaco SpA), using established methodologies as well as patient-reported outcomes.

Methods

This is a prospective observational study being undertaken in a target population of 228 healthy Italian women aged 18-35 years who are starting oral contraception for the first time or switching from another COC. The participants are asked to complete a diary for 6 cycles recording information about their menstrual cycles (frequency, duration, regularity, estimated flow volume, and breakthrough bleeding), any unscheduled bleeding, and an evaluation of dysmenorrhea, using a 100-mm visual analog scale from 0=no pain to 100=very severe pain, and any adverse events. Compliance is assessed after 3 and 6 months via returned medication. The primary end point is the change from baseline in the rate of intermenstrual bleeding during the sixth cycle. At baseline, 3 months, and 6 months, acne will also be assessed using the Global Acne Grading Scale, and participants will complete a Profile of Mood State to assess premenstrual syndrome and the Female Sexual Function Index to evaluate the quality of their sex life. A subgroup of 28 participants at 1 site (Genoa) is also providing a blood sample for the assessment of metabolic, endocrine, and coagulation parameters.

Results

Study enrollment began in July 2023 and is expected to be complete by December 2024. Data analysis is expected to be complete by October 2025.

Conclusions

This study into the effects of monophasic NGM/EE 0.25/0.035 mg on menstrual characteristics in healthy Italian women will provide up-to-date data on these effects and includes assessments of a range of other parameters, such as acne severity and patient-reported outcomes, in line with recent international consensus recommendations. Trial Registration ClinicalTrials.gov NCT06067256; https://clinicaltrials.gov/study/NCT06067256 and EudraCT 2021-003027-15; https://www.clinicaltrialsregister.eu/ctr-search/trial/2021-003027-15/IT International Registered Report Identifier (IRRID) DERR1-10.2196/63683

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Contraceptives, Oral, CombinedEthinyl EstradiolMenstruationNorgestrelAdolescentAdultFemaleHumansYoung AdultDrug CombinationsItalyMenstrual CycleMulticenter Studies as TopicProspective StudiesClinical Trials, Phase IV as Topic

Stichwörter der Autor:innen

Italyassessmentcombined oral contraceptivedata analysisethinyl estradiolhormonal contraceptivemenstrual cyclemenstrual healthmethodologymonophasicnorgestimateobservational studypatient-reported outcomesreproductive healthwomen’s health

Substanzen

Contraceptives, Oral, CombinedDrug CombinationsEthinyl EstradiolnorgestimateNorgestrel

Autor:innen und Institutionen

  • Dipartimento di Neuroscienze, Riabilitazione, Oftalmologia e Scienze Materno Infantili, Istituto di Recerca e di Cura e Carattere Scientifico (IRCSS)-Ospedale San Martino, Genoa, Italy.
  • Dipartimento di Scienze Mediche e Chirurgiche Materno-Infantili e dell'Adulto, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy.
  • Dipartimento di Scienze Mediche, Chirurgiche e Sperimentali, Università degli Studi-Azienda Ospedaliero Universitaria di Sassari, Sassari, Italy.
  • Dipartimento di Scienze Chirurgiche, Policlinico Universitario Monserrato Duilio Casula, Monserrato, Italy.
  • Dipartimento della Mamma e dei Bambini, Unità Operativa Semplice Procreazione Medicalmente Assistita del Policlinico Le Scotte, Siena, Italy.
  • Unità Operativa Ostetricia e Ginecologia, Ospedale San Pio da Pietrelcina, Vasto, Italy.

ORCID-Profile: Angelo Cagnacci, Giovanni Grandi, Giampiero Capobianco, Anna Maria Fulghesu, Giuseppe Morgante, Vincenzo Biondelli, Elena Piccolo, Elena Casolati, Mario Mangrella

Zitieren

APA

Cagnacci, A., Grandi, G., Capobianco, G., Fulghesu, A. M., Morgante, G., Biondelli, V., Piccolo, E., Casolati, E., & Mangrella, M. (2025). Effects of a Monophasic Hormonal Contraceptive With Norgestimate+Ethinyl Estradiol on Menstrual Bleeding: Protocol and Design of a Multicenter, Prospective, Open-Label, Noncomparative Study in Italy. JMIR Research Protocols. https://doi.org/10.2196/63683

Vancouver

Cagnacci A, Grandi G, Capobianco G, Fulghesu AM, Morgante G, Biondelli V, et al. Effects of a Monophasic Hormonal Contraceptive With Norgestimate+Ethinyl Estradiol on Menstrual Bleeding: Protocol and Design of a Multicenter, Prospective, Open-Label, Noncomparative Study in Italy. JMIR Research Protocols. 2025. doi:10.2196/63683

BibTeX
@article{Cagnacci2025,
  author = {Cagnacci, Angelo and Grandi, Giovanni and Capobianco, Giampiero and Fulghesu, Anna Maria and Morgante, Giuseppe and Biondelli, Vincenzo and Piccolo, Elena and Casolati, Elena and Mangrella, Mario},
  title = {Effects of a Monophasic Hormonal Contraceptive With Norgestimate+Ethinyl Estradiol on Menstrual Bleeding: Protocol and Design of a Multicenter, Prospective, Open-Label, Noncomparative Study in Italy},
  journal = {JMIR Research Protocols},
  year = {2025},
  doi = {10.2196/63683}
}
Kostenlos starten →